InMed to Present at Cannabis-Based Science & Medicine Conference

43

InMed Pharmaceuticals Inc. (CNW Group/InMed Pharmaceuticals Inc.)CSE: INOTCQB: IMLFF VANCOUVER, Nov. 16, 2017 /PRNewswire/ – InMed Pharmaceuticals, Inc. (“InMed” or the “Company”) (CSE:IN; OTCQB: IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, announced today it will…


https://www.prnewswire.com/news-releases/inmed-to-present-at-cannabis-based-science–medicine-conference-657943153.html